Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 321 artículos Viendo del 81 al 120 de 321 artículos
Pub MED

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.NUEVO

Chen G, Liu J, Jiang L, Ran X, He D, Li Y, Huang B, Wang W, Fu S.
Int J Mol Sci. 2017 Dec 21;19(1). pii: E12. doi: 10.3390/ijms19010012.
Pub MED

Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.NUEVO

Dafsari HS, Reker P, Silverdale M, Reddy P, Pilleri M, Martinez-Martin P, Rizos A, Perrier E, Weiß L, Ashkan K, Samuel M, Evans J, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non-Motor PD Study Group..
Neuromodulation. 2017 Dec 20. doi: 10.1111/ner.12740. [Epub ahead of print]
Pub MED

Navigating Interprofessional Spaces: Experiences of Clients Living with Parkinson's Disease, Students and Clinical Educators.NUEVO

Friary P, Tolich J, Morgan J, Stewart J, Gaeta H, Flood B, McNaughton S.
J Interprof Care. 2017 Dec 21:1-9. doi: 10.1080/13561820.2017.1417238. [Epub ahead of print]
Pub MED

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.NUEVO

Pagano G, Niccolini F, Politis M.
J Neural Transm (Vienna). 2017 Dec 20. doi: 10.1007/s00702-017-1823-7. [Epub ahead of print] Review.
Pub MED

Author Correction: Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease.NUEVO

Roy S.
Nat Neurosci. 2017 Dec 20. doi: 10.1038/s41593-017-0035-7. [Epub ahead of print]
Pub MED

Drug-induced Pressure Ulcers in a Middle-aged Patient with Early-stage Parkinson's Disease.NUEVO

Hayashi Y, Shibata H, Kudo T, Nishida S, Ishikawa R, Moriya C, Suzuki A, Kimura A, Inuzuka T.
Intern Med. 2017 Dec 27. doi: 10.2169/internalmedicine.9700-17. [Epub ahead of print]
Pub MED

Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.NUEVO

Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K, Mordes DA, Olson SH, Prusiner SB.
Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 201719369. doi: 10.1073/pnas.1719369115. [Epub ahead of print]
Pub MED

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.NUEVO

Marrinan SL, Otiker T, Vasist LS, Gibson RA, Sarai BK, Barton ME, Richards DB, Hellström PM, Nyholm D, Dukes GE, Burn DJ.
Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27259. [Epub ahead of print]
Pub MED

Prevalence of and indications for antipsychotic use in Parkinson's disease.NUEVO

Bower JH, Grossardt BR, Rocca WA, Savica R.
Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27256. [Epub ahead of print]
Pub MED

Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?NUEVO

Morgan AH, Rees DJ, Andrews ZB, Davies JS.
Neuropharmacology. 2017 Dec 22. pii: S0028-3908(17)30624-X. doi: 10.1016/j.neuropharm.2017.12.027. [Epub ahead of print] Review.
Pub MED

A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.NUEVO

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Mišić B, Dagher A.
Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31074-1. doi: 10.1016/j.neuroimage.2017.12.050. [Epub ahead of print] Review.
Pub MED

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease.NUEVO

Fabricius K, Barkholt P, Jelsing J, Hansen HH.
Front Neuroanat. 2017 Dec 8;11:109. doi: 10.3389/fnana.2017.00109. eCollection 2017.
Pub MED

Average annual cost of Parkinson's disease in São Paulo, Brazil, with a focus on disease-related motor symptoms.NUEVO

Bovolenta TM, de Azevedo Silva SMC, Saba RA, Borges V, Ferraz HB, Felicio AC.
Clin Interv Aging. 2017 Dec 14;12:2095-2108. doi: 10.2147/CIA.S151919. eCollection 2017.
Pub MED

Altered kinematics of arm swing in Parkinson's disease patients indicates declines in gait under dual-task conditions.NUEVO

Baron EI, Miller Koop M, Streicher MC, Rosenfeldt AB, Alberts JL.
Parkinsonism Relat Disord. 2017 Dec 19. pii: S1353-8020(17)30843-X. doi: 10.1016/j.parkreldis.2017.12.017. [Epub ahead of print]
Pub MED

[Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].NUEVO

Sun YQ, Zhang Q, Jiang Z, Zhang CY, Zhang JW, Chen H, Shen JK.
Zhonghua Yi Xue Za Zhi. 2017 Dec 5;97(45):3534-3537. doi: 10.3760/cma.j.issn.0376-2491.2017.45.004. Chinese.
Pub MED

Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT images.NUEVO

Oliveira FPM, Faria DB, Costa DC, Castelo-Branco M, Tavares JMRS.
Eur J Nucl Med Mol Imaging. 2017 Dec 23. doi: 10.1007/s00259-017-3918-7. [Epub ahead of print]
Pub MED

Comorbid Conditions in Parkinson's Disease: A Population-Based Study of Statewide Parkinson's Disease Registry.NUEVO

Xu K, Alnaji N, Zhao J, Bertoni JM, Chen LW, Bhatti D, Qu M.
Neuroepidemiology. 2017 Dec 22;50(1-2):7-17. doi: 10.1159/000484410. [Epub ahead of print]
Pub MED

Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.NUEVO

Wang L, Nie K, Zhao X, Feng S, Xie S, He X, Ma G, Wang L, Huang Z, Huang B, Zhang Y, Wang L.
Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020-0. doi: 10.1016/j.neulet.2017.12.047. [Epub ahead of print]
Pub MED

Altered functional connectivity of the subthalamic nucleus during self-initiated movement in Parkinson's disease.NUEVO

Jia Q, Gao L, Zhang J, Wu T, Chan P.
J Neuroradiol. 2017 Dec 19. pii: S0150-9861(17)30397-8. doi: 10.1016/j.neurad.2017.11.008. [Epub ahead of print]
Pub MED

Empirical Wavelet Transform Based Features for Classification of Parkinson's Disease Severity.NUEVO

Oung QW, Muthusamy H, Basah SN, Lee H, Vijean V.
J Med Syst. 2017 Dec 29;42(2):29. doi: 10.1007/s10916-017-0877-2.
Pub MED

LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein.NUEVO

Yan W, Chen ZY, Chen JQ, Chen HM.
Biochem Biophys Res Commun. 2017 Dec 26. pii: S0006-291X(17)32551-2. doi: 10.1016/j.bbrc.2017.12.149. [Epub ahead of print]
Pub MED

Passive smoking and Parkinson's disease in California teachers: Methodological issues.NUEVO

Ashrafi-Asgarabad A, Safiri S.
Parkinsonism Relat Disord. 2017 Dec 21. pii: S1353-8020(17)30844-1. doi: 10.1016/j.parkreldis.2017.12.018. [Epub ahead of print] No abstract available.
Pub MED

Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.NUEVO

Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M, Miltenberger-Miltényi G, Borovecki F, Soreq H, Ferreira JJ, Outeiro TF.
PLoS One. 2017 Dec 28;12(12):e0190552. doi: 10.1371/journal.pone.0190552. eCollection 2017.
Pub MED

Update on Molecular Imaging in Parkinson's Disease.NUEVO

Liu ZY, Liu FT, Zuo CT, Koprich JB, Wang J.
Neurosci Bull. 2017 Dec 27. doi: 10.1007/s12264-017-0202-6. [Epub ahead of print] Review.
Pub MED

Anesthetic management for retrieval of a large aspirated denture in a patient with Parkinson's disease.NUEVO

Chen K, Ye M, Shen X.
J Clin Anesth. 2017 Dec;43:59-60. doi: 10.1016/j.jclinane.2017.09.016. Epub 2017 Oct 3. No abstract available.
Pub MED

The Cats-and-Dogs test: A tool to identify visuoperceptual deficits in Parkinson's disease.NUEVO

Weil RS, Pappa K, Schade RN, Schrag AE, Bahrami B, Schwarzkopf DS, Crutch SJ, O'Keeffe AG, Morris HR.
Mov Disord. 2017 Dec;32(12):1789-1790. doi: 10.1002/mds.27176. Epub 2017 Oct 4. No abstract available.
Pub MED

Structural connectome alterations in prodromal and de novo Parkinson's disease patients.NUEVO

Wen MC, Heng HSE, Hsu JL, Xu Z, Liew GM, Au WL, Chan LL, Tan LCS, Tan EK.
Parkinsonism Relat Disord. 2017 Dec;45:21-27. doi: 10.1016/j.parkreldis.2017.09.019. Epub 2017 Sep 21.
Pub MED

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.NUEVO

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators..
Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.
Pub MED

Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.NUEVO

Delgado-Camprubi M, Esteras N, Soutar MP, Plun-Favreau H, Abramov AY.
Cell Death Differ. 2017 Dec;24(12):2210. doi: 10.1038/cdd.2017.175. Epub 2017 Oct 13.
Pub MED

A LOW BLOOD COPPER CONCENTRATION IS A CO-MORBIDITY BURDEN FACTOR IN PARKINSON'S DISEASE DEVELOPMENT.NUEVO

Ilyechova EY, Miliukhina IV, Orlov IA, Muruzheva ZM, Puchkova LV, Karpenko MN.
Neurosci Res. 2017 Dec 1. pii: S0168-0102(17)30383-8. doi: 10.1016/j.neures.2017.11.011. [Epub ahead of print]
Pub MED

Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.NUEVO

Kumar V, Singh D, Singh BK, Singh S, Mittra N, Jha RR, Patel DK, Singh C.
Mol Cell Biochem. 2017 Dec 2. doi: 10.1007/s11010-017-3239-y. [Epub ahead of print]
Pub MED

Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.NUEVO

Cammisuli DM, Sportiello MT.
Psychiatr Danub. 2017 Dec;29(4):437-445. doi: 10.24869/psyd.2017.437.
Pub MED

Altered resting-state brain activity in Parkinson's disease patients with freezing of gait.NUEVO

Mi TM, Mei SS, Liang PP, Gao LL, Li KC, Wu T, Chan P.
Sci Rep. 2017 Dec 1;7(1):16711. doi: 10.1038/s41598-017-16922-0.
Pub MED

Translating scientific advances into disease-modifying therapies for Parkinson's Disease.NUEVO

Cenci MA, Olanow CW.
Exp Neurol. 2017 Dec;298(Pt B):135-136. doi: 10.1016/j.expneurol.2017.10.011. No abstract available.
Pub MED

Mechanistic evaluation of neuroprotective effect of estradiol on rotenone and 6-OHDA induced Parkinson's disease.NUEVO

Shen D, Tian X, Zhang B, Song R.
Pharmacol Rep. 2017 Dec;69(6):1178-1185. doi: 10.1016/j.pharep.2017.06.008. Epub 2017 Jul 8.
Pub MED

ABCB1: is there a role in the drug treatment of Parkinson's disease?NUEVO

Müller T.
Expert Opin Drug Metab Toxicol. 2017 Dec 12:1-3. doi: 10.1080/17425255.2018.1416096. [Epub ahead of print] No abstract available.
Pub MED

Well-being and distress of patients with Parkinson's disease: a comparative investigation.NUEVO

Vescovelli F, Sarti D, Ruini C.
Int Psychogeriatr. 2017 Dec 10:1-10. doi: 10.1017/S1041610217002575. [Epub ahead of print]
Pub MED

Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.NUEVO

Chen HM, Sha ZQ, Ma HZ, He Y, Feng T.
CNS Neurosci Ther. 2017 Dec 8. doi: 10.1111/cns.12783. [Epub ahead of print]
Pub MED

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.NUEVO

Jellinger KA.
J Neural Transm (Vienna). 2017 Dec 8. doi: 10.1007/s00702-017-1821-9. [Epub ahead of print] Review.
Pub MED

Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson's Disease.NUEVO

Pinto M, Nissanka N, Moraes CT.
J Neurosci. 2017 Dec 8. pii: 1384-17. doi: 10.1523/JNEUROSCI.1384-17.2017. [Epub ahead of print]
Viendo del 81 al 120 de 321 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.